Health Canada to Implement ICH E6(R3): What It Means and How to Prepare 

Health Canada to Implement ICH E6(R3): What It Means and How to Prepare 

On October 17th, Health Canada has confirmed it will implement the ICH E6(R3) Good Clinical Practice (GCP) guideline, a major international update to the way clinical trials are designed, managed, and documented. The goal is to strengthen participant safety, improve data quality, and modernize how clinical research is conducted in Canada. …
Read More
NHP Clinical Trials – Feasibility and Portfolio Assessment

NHP Clinical Trials – Feasibility and Portfolio Assessment

Clinical trials for natural health products (NHPs) such as vitamins, herbal remedies, and probiotics bring scientific rigour to traditional health claims. In Canada, where consumer protection and evidence-based regulation are priorities, sponsors are beginning to shift away from running isolated trials toward building comprehensive clinical research strategies. This shift reflects…
Read More
Advancing Health Innovation Through Clinical Research at the SNI Clinic

Advancing Health Innovation Through Clinical Research at the SNI Clinic

In today’s increasingly competitive and informed health and wellness marketplace, scientific validation is no longer optional - it is a critical component of building consumer trust, meeting regulatory requirements, and ensuring long-term product success. As consumers become more educated and discerning about the health products they use, they demand proof…
Read More